Table 4.
IHC staining indices of the HER2 pathway markers and percentages of the Ki67-positive cells in the baseline tumors*
PR (N=2) |
SD/PD (N=6) |
|||
---|---|---|---|---|
Markers | Median | Range | Median | Range |
pHER2-Y1248 | 56.0 | 54.3–57.7 | 3.7 | 0–44.0** |
pHER2-Y877 | 38.8 | 33.4–44.1 | 3.3 | 0–44.5 |
pMAPK | 56.6 | 42.4–70.8 | 33.7 | 12.9–90.1 |
pAkt | 13.5 | 4.2–22.7 | 1.6 | 0–36.8 |
HER2 | 64.3 | 61.6–67.1 | 74.6 | 18.7–91.5 |
Ki67† | 49.4 | 37.2–61.6 | 57.4 | 18.6–95.3 |
IHC staining index = (staining intensity of a sample – staining intensity of negative control) × percentage of stained cells /100. (30)
p-value = 0.095
Percentages of IHC stained cells.
Abbreviations: IHC, immunohistochemistry; PR, partial response; SD, stable disease; PD, progressive disease.